- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03705299
Non-Invasive CVP Method to Standard CVP Method
A Prospective, Comparative Study to Evaluate the Accuracy of a Non-Invasive Central Venous Pressure Method to the Standard CVP Method
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Standard CVP Method
The CVP line is inserted into the internal jugular vein central venous catheter or subclavian vein catheter and threaded to the point where the superior vena cava meets the inferior vena cava prior to entry into the right atrium of the heart. The catheter is hooked to a pressure bag which is pressurized to 200 cm water. This pressure allows the infusion of about 3ml of fluid each hour but keeps the line patent. The distal tip of the CVP line is connected to a transducer and taped to the arm at a level which is in line with the heart.
Research Procedure (non-invasive CVP Method)
A physiologic data acquisition system (Zoe Medical, Topsfield MA)) will be used to monitor CVP, upper arm impedance changes, and upper arm cuff pressures.
The subject's CVP pressure transducer will be zeroed at the level of the right atrium (midaxillary line) with the use of a carpenter's level.
A tetra-polar impedance configuration will be used to measure upper arm impedance. A pair of current-injecting electrodes will be placed in positions 1 & 4 and two sensing electrodes will be placed in positions 2 & 3 (where a traditional blood pressure cuff would be positioned, overlying the brachial-axillary vein system). These leads extend from the Zoe Medical device. (Figure 1 taken from Ward et al., in press).
Electrobioimpedance will be measured in the upper portion of an upper extremity using an electrobioimpedance amplifier contained within the Zoe Medical device. A constant current source (1mA, 100kHz) will be sent through the current electrode and the voltage drop between the two sensing electrodes will be amplified.
A blood pressure cuff attached to the Zoe Medical Device will be positioned over the two sensing electrodes.
The cuff pressure will be quickly inflated to a value higher than CVP but lower than the diastolic arterial pressure (40 mm Hg) and kept at that pressure for 45-60 seconds.
At the end of the inflation hold period, release the cuff pressure valve and open to atmosphere to allow rapid self-deflation
Repeat measures 3 times in each subject for a period of 10 minutes
If the subject requires volume resuscitation, diuresis, or are administered inotropic drugs, we will reevaluate CVP with the non-invasive method during these circumstances. CVP will be measured every 1 minute to capture rapid changes in CVP. The length of time that the investigators monitor CVP will depend on the length of time required to detect changes in CVP.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients aged ≥ 18 years
- Require CVP monitoring in the supine position as part of routine care
- Central venous access obtained by either internal or external jugular, or subclavian vein
Exclusion Criteria:
- Patients aged < 18 years
- Patients who are pregnant
- Patients that will be in the prone position
- Central venous access obtained by the femoral vein
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: NeuMeDex NICVP (Non-Invasive CVP) vs Standard CVP
Three pressure readings recorded for both NeuMeDex NICVP and central line pressure catheter over a 10 minute period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessing if the NeuMeDx NICVP device is as effective as the standard invasive method at measuring CVP in patients that require central catheter placement and monitoring.
Time Frame: 6 months
|
The primary objective of the study is to measure the CVP using the NeuMeDx NICVP (Non-Invasive Central Venous Pressure) device.
The critical endpoint is the average of the average of three CVP, by calibrated forced transducer, and NICVP measurements in mmHg over a 10-minute period in a patient in the supine position.
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Irwin Gratz, DO, The Cooper Health System
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 12-121
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Central Venous Pressure
-
Pakistan Navy Station Shifa HospitalCompletedCentral Venous Pressure | Peripherial Venous Pressure | Fluid/Volume Status Monitoring of PatientPakistan
-
Boston Children's HospitalMespere Lifesciences Inc.TerminatedCentral Venous PressureUnited States
-
Charite University, Berlin, GermanyCompleted
-
University of OklahomaTerminatedHemodynamics | Central Venous PressureUnited States
-
University of IowaCompleted
-
First People's Hospital of ChenzhouNot yet recruitingHepatectomy | Sildenafil | Hemodynamics Instability | Central Venous PressureChina
-
University Hospital, Basel, SwitzerlandCompletedUltrasonic Diagnosis | Venous Pressure, CentralSwitzerland
-
University of IowaCompletedCentral Venous PressureUnited States
-
Mespere Lifesciences Inc.University of MichiganCompletedCentral Venous PressureUnited States
-
Mahidol UniversityCompletedCentral Venous Pressure | Internal Jugular Size Measured by UltrasoundThailand
Clinical Trials on Non-Invasive CVP vs Standard CVP
-
Mespere Lifesciences Inc.Wayne State UniversityUnknownSevere Sepsis | Acute Heart FailureUnited States
-
Stefano Malinverni, MDAndre Vesale AssociationRecruitingCardiac Arrest With Successful ResuscitationBelgium
-
Ottawa Hospital Research InstituteZimmer BiometCompletedOsteoarthritis | Hip Arthroplasty
-
Institut Cancerologie de l'OuestDirection Générale de l'Offre de SoinsUnknownPulmonary Complication | Surgical PatientsFrance
-
Montefiore Medical CenterRecruiting
-
FENG Ji-fengChinese Anti-Cancer AssociationUnknownDiffuse Large B-cell LymphomaChina
-
Research Center BorstelSuspended
-
Università Vita-Salute San RaffaeleActive, not recruitingEarly Acute Respiratory FailureItaly, Kazakhstan, Greece
-
Institute for Clinical Evaluative SciencesCanadian Institutes of Health Research (CIHR); Ontario Agency for Health Protection... and other collaboratorsCompletedAntibiotic Initiation | Antibiotic DurationCanada
-
Poitiers University HospitalUnknownExtubation | Work of Breathing | ICU | Non-invasive Ventilation | Tidal Volume | Respiratory Effort | High-Flow Nasal Oxygen TherapyFrance